NVE CORP (NVEC)
Sector: Information Technology
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Information Technology
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for NVEC
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NVEC | 57 | ["Experience as a director at other publicly-traded companies","Senior executive experience at a publicly-traded company","Experience managing cybersecurity risks","Experience aligning compensation with strategy and performance","Independent of Management"] | [] | 2026 |
Biography sourced from the proxy statement filing.
Carolyn W. Valentine is a first-time nominee to our Board of Directors. Ms. Valentine has served as President of Grason-Stadler (GSI), a Demant Company, since October 2023. Demant is a publicly traded hearing healthcare and audio technology group, and GSI is a world leader in audiology equipment. From 2018 to 2023, Ms. Valentine served as Vice President and General Manager of Demant s Philips, Sonic, and Bernafon hearing aid lines. From 2012 to 2017, Ms. Valentine held several executive positions at Johnson & Johnson (J&J), a publicly traded multinational pharmaceutical, biotechnology, and medical technologies company, most recently serving as Vice President, Enterprise Customers Group, J&J Medical Devices. Earlier in her career, she held positions at Abbott Laboratories, Conagra Foods, and the Kraft Heinz Company (formerly Kraft Foods). Ms. Valentine holds a B.A. in French Studies and Communications from the University of Cincinnati and an MBA from Indiana University. Ms. Valentine s executive leadership, medical device, electronic manufacturing, and public company experience qualify her to serve as an NVE director.